Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05212233 · ClinicalTrials.gov registry record

Financial Difficulty in Patients With Blood Cancer

A clinical trial, sponsored by UNC Lineberger Comprehensive Cancer Center.

Completed
Registry status
218
Enrollment target

NCT05212233 is a clinical trial that has completed, run by UNC Lineberger Comprehensive Cancer Center. The registered enrollment target is 218 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05212233 has completed, sponsored by UNC Lineberger Comprehensive Cancer Center.

COMPLETED
Registry status
218 participants
Enrollment target

Study Summary

This is a hypothesis-driven, observational, cross-sectional, multi-site study of the financial difficulties experienced by patients undergoing treatment for multiple myeloma (MM) and chronic lymphocytic leukemia (CLL). It is composed of a patient survey (n=250) (Appendix A), a physician survey (n=100) (Appendix B), and a practice survey completed by each site enrolling patients onto this study (Appendix C). A subset of enrolled patients (n=35) will be invited to participate in an optional second telephone interview (Appendix D). This study will measure the prevalence of patient-reported financial difficulty, specific financial burdens and resources currently available to patients and from practices to assist with patient financial navigation.

Trial Details

FieldValue
Enrollment Target 218 participants
Start Date 2022-01-27
Est. Completion 2025-02-26

What the Registry Record Tells You About NCT05212233

The ClinicalTrials.gov registry entry for NCT05212233 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 218 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is UNC Lineberger Comprehensive Cancer Center, which has 366 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 0 interventions.

NCT05212233 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT05212233 about?

NCT05212233 is a clinical study titled "Financial Difficulty in Patients With Blood Cancer". This is a hypothesis-driven, observational, cross-sectional, multi-site study of the financial difficulties experienced by patients undergoing treatment for multiple myeloma (MM) and chronic lymphocytic leukemia (CLL). It is composed of a patient survey (n=250) (Appendix A), a physician survey (n=10...

What is the current status of trial NCT05212233?

This trial is currently completed. The enrollment target is 218 participants. The study started on 2022-01-27. Estimated completion is 2025-02-26.

Who is sponsoring clinical trial NCT05212233?

This trial is sponsored by UNC Lineberger Comprehensive Cancer Center, which has 366 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.